• N1-Methyl-Pseudouridine-5'-Triphosphate: Engineering RNA Sta

  2026-07-20

  Explore the advanced role of N1-Methyl-Pseudouridine-5'-Triphosphate in boosting RNA stability and translational fidelity. This in-depth analysis reveals new insights for mRNA vaccine development and in vitro transcription with modified nucleotides.

• RG7388 MDM2 Antagonist: Applied Oncology Workflows & Optimiz

  2026-07-20

  RG7388, a next-generation MDM2 antagonist, enables precise activation of the p53 pathway for robust cancer cell apoptosis induction, especially in wild-type p53 models. This guide delivers actionable protocols, troubleshooting strategies, and applied use-cases for maximizing translational oncology impact with RG7388.

• Trelagliptin Succinate: Evidence-Based Insights for Type 2 D

  2026-07-19

  Trelagliptin succinate (SYR-472 succinate) is a long-acting, selective DPP-4 inhibitor with proven glucose-lowering and insulin-sensitizing effects in type 2 diabetes research. Its unique weekly dosing, well-characterized mechanism, and multi-domain applications make it a pivotal molecule for metabolic and cellular studies.

• Pronase E Protease Mixture: Precision Protein Digestion Work

  2026-07-18

  Pronase E delivers unmatched versatility in protein sample preparation, enabling reproducible and high-resolution proteomic analysis, especially in complex oncology research. Learn how to optimize workflows, troubleshoot common pitfalls, and leverage insights from cutting-edge studies to maximize your experimental success.

• Solanesol: Technical Handling and Protocol Guidance

  2026-07-17

  Solanesol is a high-purity polyisoprenoid alcohol designed for research workflows that require rigorous management of hydrophobic compounds, such as apoptosis research, DNA damage and repair studies, and metabolic enzyme assays. It is not suitable for diagnostic, clinical, or aqueous/ethanol-based systems and should be handled following precise solubility and storage parameters.

• ECL Chemiluminescent Substrate Detection Kit: Hypersensitive

  2026-07-17

  Unlock ultrasensitive immunoblotting with the ECL Chemiluminescent Substrate Detection Kit (Hypersensitive), enabling reliable detection of low-abundance proteins with prolonged signal duration. This guide translates the latest research and laboratory best practices into actionable workflows, empowering researchers to optimize Western blot chemiluminescent detection for even the most challenging samples.

• Strategic Use of TMRE Assays for Mitochondrial Dysfunction I

  2026-07-16

  This thought-leadership article explores how the TMRE mitochondrial Membrane Potential Assay Kit empowers translational researchers to dissect mitochondrial mechanisms in apoptosis and sodium-induced cell death (NECSO), with actionable protocol guidance and an outlook on future research frontiers.

• Optimizing Apoptosis Assays with ABT-199 (GDC-0199), Bcl-2 I

  2026-07-16

  This article delivers scenario-driven, data-backed strategies for overcoming common challenges in apoptosis and viability assays using ABT-199 (GDC-0199), Bcl-2 inhibitor, potent and selective (SKU A8194). Drawing on peer-reviewed studies and validated product features, we outline practical solutions for reproducibility, selectivity, and experimental workflow in hematologic and solid tumor research. APExBIO’s ABT-199 is emphasized as a reliable, high-purity choice for sensitive and selective Bcl-2 inhibition.

• Muscle-Derived BDNF and MMPs Regulate Early NMJ Formation

  2026-07-15

  This study uncovers how muscle-generated BDNF, spatially localized and proteolytically processed by furin and matrix metalloproteinases (MMPs), directs the initial assembly of postsynaptic acetylcholine receptor clusters at neuromuscular junctions. The findings reveal a mechanistic framework for activity-dependent synaptic development and offer actionable insights for modulating NMJ assembly in vitro and in vivo.

• Cdk5 Downregulation Mitigates Neuronal Ferroptosis via AMPK

  2026-07-15

  This study demonstrates that inhibiting Cdk5 in mouse models of ischemic stroke reduces hippocampal neuron ferroptosis by modulating the AMPK pathway and microglial polarization. The findings provide mechanistic insight into neuroinflammation and ferroptosis, supporting the development of targeted interventions for neuronal injury.

• Protease Inhibitor Cocktail EDTA-Free: Unveiling Molecular P

  2026-07-14

  Discover how the Protease Inhibitor Cocktail EDTA-Free (100X in DMSO) enables unparalleled protein integrity during extraction and advanced assay workflows. Gain new insights into inhibitor selection and molecular stability, grounded in recent nanobiotech research.

• AZD0156: ATM Kinase Inhibitor Workflows for DNA Repair Resea

  2026-07-14

  AZD0156 accelerates high-fidelity DNA damage response studies by providing potent, selective ATM kinase inhibition for cancer therapy research. This article guides researchers through robust experimental setups, advanced troubleshooting, and data-driven protocol optimization to unlock reproducible results.

• Cy3-UTP for RNA Labeling: Enhanced Imaging & Interaction Ass

  2026-07-13

  Cy3-UTP empowers researchers to generate photostable, high-sensitivity fluorescent RNA for advanced imaging and RNA-protein interaction studies. Its robust incorporation streamlines in vitro transcription workflows and delivers reproducible results ideal for kinetic and structural RNA biology assays.

• Atorvastatin: HMG-CoA Reductase Inhibitor in Advanced Resear

  2026-07-13

  Atorvastatin is not only an essential HMG-CoA reductase inhibitor for cholesterol metabolism research but also a validated tool for studying ferroptosis and vascular cell biology. This article provides actionable protocols, troubleshooting tips, and a translational outlook for Atorvastatin’s multifaceted roles in both cardiovascular and oncology models.

• 25-Hydroxycholesterol Drives AMPK-STAT6 Axis in Tumor Macrop

  2026-07-12

  Xiao et al. unveil a lysosome-centered mechanism in which 25-hydroxycholesterol (25HC) accumulates within tumor-associated macrophages (TAMs), activating AMPKα through a GPR155-mTORC1 complex and initiating STAT6-dependent immunosuppressive programming. These findings clarify metabolic reprogramming in TAMs and suggest new angles for therapeutic intervention in the tumor microenvironment.

15835 records 1/1056 page Next 12345 下5页 Last page